κ-opioid Receptor Gene as a Predictor of Response in a Cocaine Vaccine Clinical Trial

Por Nielsen, D.A., Hamon, S.C., Kosten, T.R.
Publicado em 2013

Modifying Role of Serotonergic 5-HTTLPR & TPH2 Variants on Disulfiram Treatment of Cocaine Addiction: A Preliminary Study

Por Nielsen, D.A., Harding, M. J., Hamon, S.C., Huang, W., Kosten, T.R.
Publicado em 2012

Bidirectional Translational Research: Progress in Understanding Addictive Diseases

Por Kreek, MJ, Schlussman, SD, Reed, B, Zhang, Y, Nielsen, DA, Levran, O, Zhou, Y, Butelman, ER
Publicado em 2008

Genotype patterns that contribute to increased risk for or protection from developing heroin addiction

Por Nielsen, DA, Ji, F, Yuferov, V, Ho, A, Chen, A, Levran, O, Ott, J, Kreek, MJ
Publicado em 2008

Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and α(1A)-adrenoceptor gene variation

Por Shorter, D., Nielsen, D.A., Huang, W., Harding, M. J., Hamon, S.C., Kosten, T.R.
Publicado em 2013